chr2-200925902-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006190.5(ORC2):c.1081G>A(p.Asp361Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000276 in 1,591,502 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006190.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ORC2 | NM_006190.5 | c.1081G>A | p.Asp361Asn | missense_variant | 13/18 | ENST00000234296.7 | NP_006181.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ORC2 | ENST00000234296.7 | c.1081G>A | p.Asp361Asn | missense_variant | 13/18 | 1 | NM_006190.5 | ENSP00000234296 | P1 | |
ORC2 | ENST00000464147.1 | n.168G>A | non_coding_transcript_exon_variant | 2/6 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152030Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250486Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135428
GnomAD4 exome AF: 0.0000250 AC: 36AN: 1439472Hom.: 0 Cov.: 24 AF XY: 0.0000321 AC XY: 23AN XY: 716934
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152030Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74240
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 31, 2022 | The c.1081G>A (p.D361N) alteration is located in exon 13 (coding exon 11) of the ORC2 gene. This alteration results from a G to A substitution at nucleotide position 1081, causing the aspartic acid (D) at amino acid position 361 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at